The Digital Innovation Award honors pioneering use of digital, mobile, and AI technologies that are reshaping cardiovascular care. Acarix’s CADScor System is revolutionizing early cardiac diagnostics through a non-invasive, AI-driven approach that enables rapid and accurate risk assessment of coronary artery disease (CAD), empowering physicians to identify patients with stable chest pain who require further evaluation.

“We are proud to share that we were awarded the Digital Innovation Award and received an honorable mention for Innovation in Cardiac Imaging, one of only a handful of honorable mentions awarded. It is an honor to be acknowledged among the innovators advancing cardiovascular care globally,” said Aamir Mahmood, President and CEO of Acarix. “This award and honorable mention reflects our commitment to integrating advanced AI and acoustic technology to improve patient outcomes. With the CADScor System, clinicians can achieve over 96% certainty in low risk stratification, reducing unnecessary procedures and streamlining patient care pathways, which is a game-changer for both patients and healthcare providers.”

The Global Cardiovascular Awards are judged by a distinguished panel of international experts, including CEOs, clinical leaders, and key opinion leaders in cardiovascular and cardiothoracic medicine. Winners are selected through rigorous evaluation of innovations that demonstrate measurable impact on cardiovascular health worldwide.

Founded to spotlight those shaping the future of cardiovascular care, the Global Cardiovascular Awards celebrate outstanding contributions from researchers, clinicians, innovators, and organizations dedicated to advancing prevention, diagnosis, and treatment of cardiovascular disease.

###